The changing AMPK expression profile in differentiating mouse skeletal muscle myoblast cells helps confer increasing resistance to apoptosis

Experimental Physiology

Volumn 92, Issue 1, 2007, Pages 207-217

  Niesler, Carola U ^a   Myburgh, Katherine H ^a   Moore, Frances ^a,b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

6 [4 (2 PIPERIDIN 1 YLETHOXY)PHENYL] 3 PYRIDIN 4 YLPYRAZOLO[1,5 A]PYRIMIDINE; ENZYME; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; PROTEIN P50; PROTEIN P72; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ALPHA CHAIN; ANIMAL CELL; APOPTOSIS; ARTICLE; BETA CHAIN; CELL DIFFERENTIATION; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN EXPRESSION; SKELETAL MUSCLE;

EID: 33846220271     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2006.034736     Document Type: Article

References (75)

1. Abraham MC & Shaham S (2004). Death without caspases, caspases without death. Trends Cell Biol 14, 184-193.
2. Allen RT, Cluck MW & Agrawal DK (1998). Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci 54, 427-445.
3. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG et al. (2001). Activation of GLUT1 by metabolic and osmotic stress: potential involvement of AMP-activated protein kinase (AMPK). J Cell Sci 115, 2433-2442.
4. Barnoy S & Kosower NS (2003). Caspase-1-induced calpastatin degradation in myoblast differentiation and fusion: cross-talk between the caspase and calpain systems. FEBS Lett 46, 213-217.
5. Bellamy CO, Malcomson RD, Harrison DJ & Wyllie AH (1995). Cell death in health and disease: the biology and regulation of apoptosis. Semin Cancer Biol 6, 3-16.
6. Beri RK, Marley AE, See CG, Sopwith WF, Aguan K, Carling D et al. (1994). Molecular cloning, expression and chromosomal localization of human AMP-activated protein kinase. FEBS Lett 356, 117-121.
7. Bertrand L, Ginion A, Beauloye C, Hebert AD, Guigas B et al. (2006). AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B. Am J Physiol Heart Circ Physiol 291, H239-H250.
8. Beullens M, Vancauwenbergh S, Morrice N, Derua R, Ceulemans H et al. (2005). Substrate specificity and activity regulation of protein kinase MELK. J Biol Chem 280, 40003-40011.
9. Birnbaum MJ (2005). Activating AMP-activated protein kinase without AMP. Mol Cell 19, 289-290.
10. Blazquez C, Geelen MJ, Velasco G & Guzman M (2001). The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett 489, 149-153.
11. Campas C, Lopez JM, Santidrian AF, Barragan M, Bellosillo B et al. (2004). Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes. Blood 101, 3674-3680.
12. Chan TO, Rittenhouse SE & Tsichlis PN (1999). AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide dependent phosphorylation. Ann Rev Biochem 68, 965-1014.
13. Cheung PCF, Salt IP, Davies SP, Hardie DG & Carling D (2000). Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem J 346, 659-669.
14. Crameri RM, Langberg H, Magnusson P, Jensen CH, Schroder HD, Olesen JL et al. (2004). Changes in satellite cells in human skeletal muscle after a single bout of high intensity exercise. J Physiol 558, 333-340.
15. Culmsee C, Monnig J, Kemp BE & Mattson MP (2001). AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17, 45-58.
16. Darr KC & Schultz E (1987). Exercise-induced satellite cell activation in growing and mature skeletal muscle. J Appl Physiol 63, 1816-1821.
17. Datta SR, Brunet A & Greenberg ME (2006). Cellular survival: a play in three Akts. Genes Dev 13, 2905-2927.
18. Davezac N, Baldin V, Blot J, Ducommun B & Tassan JP (2002). Human pEg3 kinase associates with and phosphorylates CDC25B phosphatase: a potential role for pEg3 in cell cycle regulation. Oncogene 21, 7630-7641.
19. Dedieu S, Poussard S, Mazeres G, Grise F, Dargelos E et al. (2004). Myoblast migration is regulated by calpain through its involvement in cell attachment and cytoskeletal organization. Exp Cell Res 292, 187-200.
20. Dotto GP & Silke J (2004). More than cell death: caspases and caspase inhibitors on the move. J Dev Cell 7, 2-3.
21. Dudeck H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM et al. (1997). Regulation of serum survival by the serine-threonine protein kinase Akt. Science 275, 661-664.
22. Fernando P, Kelly JF, Balazsi K, Slack RS & Megeney LA (2002). Caspase 3 activity is required for skeletal muscle differentiation. Proc Nat Acad Sci USA 99, 11025-11030.
23. Fujio Y, Mitsuuchi Y, Testa JR & Walsh K (2001). Activation of Akt2 inhibits anoikis and apoptosis induced by myogenic differentiation. Cell Death Differ 8, 1207-1212.
24. Gao G, Fernandez CS, Stapleton D, Auster AS, Widmer J, Dyck JR et al. (1996). Non-catalytic β- and γ-subunit isoforms of the 5-AMP-activated protein kinase. J Biol Chem 271, 8675-8681.
25. Gil M, Yang Y & Ha H (1998). MPK38 expression is upregulated in immature T cells activated by concanavalin A. Immunol Lett 64, 79-83.
26. Gil M, Yang Y, Lee Y, Choi I & Ha H (1997). Cloning and expression of a cDNA encoding a novel protein serine/threonine kinase predominantly expressed in hematopoietic cells. Gene 195, 295-301.
27. Goll DE, Thompson VF, Wei W & Cong J (2003). The calpain system. Physiol Rev 83, 731-801.
28. Hardie DG (2004). The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci 117, 5479-5487.
29. Hardie DG, Carling D & Carlson M (1998). The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 67, 821-855.
30. Hawley SA, Gadalla AE, Olsen GS & Hardie DG (2002). The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51, 2420-2425.
31. Haystead T, Moore F, Cohen P & Hardie DG (1990). Roles of the AMP-activated protein kinase and the cyclic AMP-dependent protein kinase in the adrenaline-induced inactivation of acetyl-CoA carboxylase. Eur J Biochem 187, 199-205.
32. Heyer BS, Warsowe J, Solter D, Knowles BB & Ackerman SL (1997). New member of the Snf1/AMPK kinase family, Melk, is expressed in the mouse egg and preimplantation embryo. Mol Reprod Dev 47, 148-156.
33. Horman S, Vertommen D, Heath R, Neumann D, Mouton V, Woods A et al. (2006). Insulin antagonizes ischemia-induced THR172 phosphorylation of AMP-activated protein kinase α-subunits via hierarchical phosphorylation of SER485/491. J Biol Chem 281, 5335-5340.
34. Hughes SM & Blau HM (1990). Migration of myoblasts across basal lamina during skeletal muscle development. Nature 345, 350-353.
35. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y et al. (2005). AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18, 283-293.
36. Kadi F, Schjierling P, Andersen LL, Charifi N, Madsen JL et al. (2004). The effect of heavy resistance training and detraining on satellite cells in human skeletal muscle. J Physiol 558, 1005-1011.
37. Kazuyoshi K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N et al. (2002). Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 21, 6082-6089.
38. Kiess W & Gallagher B (1998). Hormonal control of programme cell death. Eur J Endocrinol 138, 482-491.
39. Kim JY, Lee JJ & Kim KS (2003). Acetyl-CoA carboxylase β expression mediated by MyoD and muscle regulatory factor 4 is differentially affected by retinoic acid receptor and retinoid X receptor. Exp Mol Med 35, 23-29.
40. King TD, Song L & Jope RS (2006). AMP-activated protein kinase (AMPK) activating agents cause dephosphorylation of Akt and glycogen synthase-3. Biochem Pharmacol 71, 1637-1647.
41. Lawlor MA & Alessi DR (2001). PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 114, 2903-2910.
42. Leff T (2003). AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31, 224-227.
43. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J et al. (2004). LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 23, 833-843.
44. Meisse D, Van de Casteele M, Beauloye C, Hainault I, Kefas BA, Rider MH et al. (2002). Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Lett 526, 38-42.
45. Milan D, Jeon JT, Looft C, Amarger V, Robic A, Thelander M et al. (2000). A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288, 1248-1251.
46. Moore F, Weekes J & Hardie DG (1991). AMP triggers phosphorylation as well as direct allosteric activation of rat liver AMP-activated protein kinase: a sensitive mechanism to protect the cell against ATP depletion. Eur J Biochem 199, 691-697.
47. Morgan JE & Partridge TA (2003). Muscle satellite cells. Int J Biochem Cell Biol 35, 1151-1156.
48. Myburgh KH (2004). Protecting muscle ATP: positive roles for peripheral defence mechanisms. Med Sci Sports Exerc 36, 16-19.
49. Nakano I, Paucar AA, Bajpai R, Dougherty JD, Zewail A, Kelly TK et al. (2005). Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation. J Cell Biol 170, 413-427.
50. Niesler CU, Urso B, Prins JB & Siddle K (2000). IGF-1 inhibits apoptosis induced by serum withdrawal, but potentiates TNFα-induced apoptosis, in 3T3-L1 preadipocytes. J Endocrinol 167, 165-174.
51. Parrizas M, Satiel AR & LeRoith D (1997). Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J Biol Chem 272, 154-161.
52. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ et al. (2003). Calcium and apoptosis: facts and hypotheses. Oncogene 22, 8619-8627.
53. Russell RR 3rd, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M et al. (2004). AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 114, 495-503.
54. Rutter GA, Da Silva Xavier G & Leclerc I (2003). Roles of 5′-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis. Biochem J 375, 1-16.
55. Salt I, Celler JW, Hawley SA, Prescott A, Woods A et al. (1998). AMP-activated protein kinase: greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem J 334, 177-187.
56. Sen P, Mukherjee S, Ray D & Raha S (2003). Involvement of the Akt/PKB signaling pathway with disease processes. Mol Cell Biochem 253, 241-246.
57. Seong HA, Gil M, Kim KT, Kim SJ & Ha H (2002). Phosphorylation of a novel zinc-finger-like protein, ZPR9, by murine protein serine/threonine kinase 38 (MPK38). Biochem J 361, 597-604.
58. Shi Y (2004). Caspase activation, inhibition, and reactivation: a mechanistic view. Protein Sci 13, 1979-1987.
59. Shiokawa D, Kobayashi T & Tanuma S (2002). Involvement of DNAase γ in apoptosis associated with myogenic differentiation of C2C12 cells. J Biol Chem 277, 31031-31037.
60. Stapleton D, Mitchelhill KI, Gao G, Widmer J, Michell BJ, Teh T et al. (1996). Mammalian AMP-activated protein kinase subfamily. J Biol Chem 271, 611-614.
61. Stapleton D, Woollatt E, Mitchelhill KI, Nicholl JK, Fernandez CS, Michell BJ et al. (1997). AMP-activated protein kinase isoenzyme family: subunit structure and chromosomal location. FEBS Lett 409, 452-456.
62. Stefanelli C, Stanic I, Bonavita F, Flamigni F, Pignatti C et al. (1998). Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4- carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase. Biochem Biophys Res Commun 243, 821-826.
63. Stewart CEH & Rotwein P (1996). Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J Biol Chem 271, 11330-11338.
64. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T & Esumi H (2003a). ARK5 suppresses the cell death induced by nutrient starvation and death receptors via inhibition of caspase 8 activation, but not by chemotherapeutic agents or UV irradiation. Oncogene 22, 6177-6182.
65. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T et al. (2003b). Identification of a novel protein kinase mediating Akt survival signalling to the ATM protein. J Biol Chem 278, 48-53.
66. Suzuki A, Kusakai G, Kishimoto A, Lu J, Ogura T et al. (2004). Regulation of caspase-6 and FLIP by the AMPK family member ARK5. Oncogene 3, 7067-7075.
67. Suzuki A, Kusakai G, Kishimoto A, Minegichi Y, Ogura T & Esumi H (2003c). Induction of cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family. Biochem Biophys Res Commun 311, 156-161.
68. Suzuki A, Ogura T & Esumi H (2006). NDR2 acts as the upstream kinase of ARK5 during insulin-like growth factor-1 signaling. J Biol Chem 281, 13915-13921.
69. Tomczak KK, Marinescu VD, Ramoni MF, Sanoudou D, Montanaro F, Han M et al. (2004). Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J 18, 403-405.
70. Vulsteke V, Beullens M, Boudrez A, Keppens S, Van Eynde A, Rider MH et al. (2004). Inhibition of spliceosome assembly by the cell cycle-regulated protein kinase MELK and involvement of splicing factor NIPP1. J Biol Chem 79, 8642-8647.
71. Walsh K & Perlman H (1997). Cell cycle exit upon myogenic differentiation. Curr Opin Genet Dev 7, 597-602.
72. Winder WW (2001). Energy sensing in skeletal muscle. J Appl Physiol 91, 1017-1028.
73. Winder WW, Wilson HA, Hardie DG, Rasmussen BB, Hutber CA, Call GB et al. (1997). Phosphorylation of rat muscle acetyl-CoA carboxylase by AMP-activated protein kinase and protein kinase A. J Appl Physiol 82, 219-225.
74. Yaffe D & Saxel O (1977). Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 270, 725-727.
75. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J et al. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167-1174.